• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铅相关性上腔静脉综合征:管理与结局。

Lead-related superior vena cava syndrome: Management and outcomes.

机构信息

University of Miami Miller School of Medicine, Miami, Florida.

The Heart Institute at Palmetto General Hospital, Palmetto General Hospital, Hialeah, Florida.

出版信息

Heart Rhythm. 2021 Feb;18(2):207-214. doi: 10.1016/j.hrthm.2020.09.006. Epub 2020 Sep 11.

DOI:10.1016/j.hrthm.2020.09.006
PMID:32920177
Abstract

BACKGROUND

Superior vena cava (SVC) syndrome includes the clinical sequalae of facial and bilateral upper extremity edema, dizziness, and occasional syncope. Historically, most cases have been associated with malignancy and treatment is palliative. However, cardiac device leads have been identified as important nonmalignant causes of this syndrome. There are little data on the effectiveness of venoplasty and lead extraction in the management of these patients.

OBJECTIVE

The objective of this study was to report the findings associated with the use of balloon angioplasty and lead extraction in the management of 17 patients with lead induced SVC syndrome.

METHODS

Data collected from January 2003 to July 2019 identified 17 cases of SVC syndrome at our tertiary center. Their outcomes were compared to a control group of patients without SVC syndrome. A P value of <.05 was considered statistically significant.

RESULTS

Of the 17 patients, 13 (76%) underwent transvenous lead extraction and venoplasty. Three patients (18%) were treated with venoplasty alone, and 1 patient (6%) underwent surgical SVC reconstruction. In 10 patients (59%), transvenous reimplantation was necessary. Symptom resolution was achieved in all 17 patients and confirmed at both 6 and 12 months' follow-up. There was no significant difference in the rate of complications associated with transvenous lead extraction for SVC syndrome vs control.

CONCLUSION

In patients with SVC syndrome, venoplasty and lead extraction are safe and effective for resolution of symptoms and maintaining SVC patency.

摘要

背景

上腔静脉(SVC)综合征包括面部和双侧上肢水肿、头晕和偶尔晕厥等临床后遗症。历史上,大多数病例与恶性肿瘤有关,治疗方法是姑息性的。然而,心脏装置导线已被确定为导致这种综合征的重要非恶性原因。关于球囊血管成形术和导线提取术在这些患者管理中的有效性的数据很少。

目的

本研究旨在报告在管理 17 例因导线引起的 SVC 综合征患者中使用球囊血管成形术和导线提取术的发现。

方法

从 2003 年 1 月至 2019 年 7 月收集的数据在我们的三级中心确定了 17 例 SVC 综合征病例。将他们的结果与没有 SVC 综合征的对照组患者进行比较。P 值<.05 被认为具有统计学意义。

结果

在 17 例患者中,13 例(76%)接受了经静脉导线提取和血管成形术。3 例(18%)单独接受了血管成形术治疗,1 例(6%)接受了 SVC 重建手术。在 10 例患者(59%)中,需要经静脉重新植入。所有 17 例患者的症状均得到缓解,并在 6 个月和 12 个月的随访中得到证实。SVC 综合征与对照组患者相比,经静脉导线提取相关并发症的发生率没有显著差异。

结论

在 SVC 综合征患者中,血管成形术和导线提取术是安全有效的,可以缓解症状并保持 SVC 通畅。

相似文献

1
Lead-related superior vena cava syndrome: Management and outcomes.铅相关性上腔静脉综合征:管理与结局。
Heart Rhythm. 2021 Feb;18(2):207-214. doi: 10.1016/j.hrthm.2020.09.006. Epub 2020 Sep 11.
2
Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices.经皮处理心血管植入式电子设备患者的上腔静脉综合征。
Heart Rhythm. 2021 Mar;18(3):392-398. doi: 10.1016/j.hrthm.2020.11.012. Epub 2020 Nov 17.
3
Percutaneous treatment of superior vena cava obstruction following transvenous device implantation.经静脉装置植入后上腔静脉阻塞的经皮治疗
Catheter Cardiovasc Interv. 2005 May;65(1):54-9. doi: 10.1002/ccd.20326.
4
Superior Vena Cava Reconstruction Using Femoropopliteal Vein as a Panel Graft.使用股腘静脉作为补片移植物进行上腔静脉重建。
Ann Vasc Surg. 2017 Oct;44:414.e15-414.e18. doi: 10.1016/j.avsg.2017.03.185. Epub 2017 May 4.
5
Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents.经皮球囊血管成形术及金属支架置入治疗起搏器导线所致上腔静脉梗阻
Eur Heart J. 2002 Sep;23(18):1465-70. doi: 10.1053/euhj.2002.3260.
6
Outcome and management of pacemaker-induced superior vena cava syndrome.起搏器所致上腔静脉综合征的结局与处理
Pacing Clin Electrophysiol. 2014 Nov;37(11):1470-6. doi: 10.1111/pace.12455. Epub 2014 Jul 17.
7
Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.经皮腔内血管内处理良性病因所致慢性上腔静脉综合征:长期随访。
Eur Radiol. 2017 Jan;27(1):97-104. doi: 10.1007/s00330-016-4354-y. Epub 2016 Apr 16.
8
Hybrid Approach for the Treatment of Superior Vena Cava Syndrome Induced by Pacemaker.混合方法治疗起搏器所致上腔静脉综合征
Ann Thorac Surg. 2017 Aug;104(2):e131-e132. doi: 10.1016/j.athoracsur.2017.02.063.
9
Endovascular Occlusion Balloon for Treatment of Superior Vena Cava Tears During Transvenous Lead Extraction: A Multiyear Analysis and an Update to Best Practice Protocol.血管内闭塞球囊治疗经静脉导线拔除术中上腔静脉撕裂:一项多年回顾分析及最佳实践方案更新。
Circ Arrhythm Electrophysiol. 2019 Aug;12(8):e007266. doi: 10.1161/CIRCEP.119.007266. Epub 2019 Aug 12.
10
Leadless pacemakers as a new alternative for pacemaker lead-related superior vena cava syndrome: A case report.无导线起搏器作为与起搏器导线相关的上腔静脉综合征的新替代方法:一例报告。
Pacing Clin Electrophysiol. 2022 Sep;45(9):1051-1055. doi: 10.1111/pace.14520. Epub 2022 Aug 1.

引用本文的文献

1
Joint Pacing and Vascular Intervention for the Management of Cardiac Device Associated Central Venous Obstruction.联合起搏与血管介入治疗心脏装置相关中心静脉阻塞
Pacing Clin Electrophysiol. 2025 Sep;48(9):959-966. doi: 10.1111/pace.70019. Epub 2025 Jul 31.
2
Superior Vena Cava Decompression After Complicated Stent Placement for Innominate Vein Obstruction in a VVI-ICD Patient.VVI型植入式心律转复除颤器(ICD)患者无名静脉梗阻复杂支架置入术后上腔静脉减压
JACC Case Rep. 2025 Apr 2;30(7):103374. doi: 10.1016/j.jaccas.2025.103374.
3
Comparison of Postoperative Outcomes between Leadless and Conventional Transvenous Pacemakers Implantation: An Up-to-Date Meta-analysis.
无导线起搏器与传统经静脉起搏器植入术后结局的比较:一项最新的荟萃分析。
Rev Cardiovasc Med. 2024 Oct 9;25(10):359. doi: 10.31083/j.rcm2510359. eCollection 2024 Oct.
4
Superior vena cava obstruction and cardiovascular implantable electronic devices-a new era of leadless devices.上腔静脉阻塞与心血管植入式电子设备——无导线设备的新时代。
Mediastinum. 2023 Dec 12;8:1. doi: 10.21037/med-23-33. eCollection 2024.
5
Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a 'heart team' approach.经皮三尖瓣置换或修复术患者的导管理:一种“心脏团队”方法。
Europace. 2023 Nov 2;25(11). doi: 10.1093/europace/euad300.
6
Recurrent Transient Ischemic Attacks in a Patient with Multiple Pacemaker Leads.一名有多根起搏器导线的患者出现复发性短暂性脑缺血发作
J Innov Card Rhythm Manag. 2023 Apr 15;14(4):5424-5430. doi: 10.19102/icrm.2023.14042. eCollection 2023 Apr.
7
Severity and Extent of Lead-Related Venous Obstruction in More Than 3000 Patients Undergoing Transvenous Lead Extraction.在 3000 多例行经静脉导线拔除术的患者中,与铅相关的静脉阻塞的严重程度和范围。
Vasc Health Risk Manag. 2022 Aug 17;18:629-642. doi: 10.2147/VHRM.S369342. eCollection 2022.
8
New Insights in Central Venous Disorders. The Role of Transvenous Lead Extractions.中心静脉疾病的新见解。经静脉导线拔除的作用。
Front Cardiovasc Med. 2022 Feb 23;9:783576. doi: 10.3389/fcvm.2022.783576. eCollection 2022.